Preterm birth: An overview of risk factors and obstetrical management

Developmental Disabilities Research Reviews

Volumn 16, Issue 4, 2010, Pages 285-288

  Stewart, Amanda ^a   Graham, Ernest ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Neonatal morbidity and mortality; Premature birth; Preterm labor

Indexed keywords

ANTIBIOTIC AGENT; BETAMETHASONE; DEXAMETHASONE; INDOMETACIN; MAGNESIUM SULFATE; PROGESTERONE; STEROID; ANTIINFECTIVE AGENT; NEUROPROTECTIVE AGENT; UTERUS SPASMOLYTIC AGENT;

AFRICAN AMERICAN; ARTICLE; CEREBRAL PALSY; CHILD DEATH; HUMAN; INFECTION; NEUROPROTECTION; OBSTETRIC PROCEDURE; PREGNANCY; PREMATURE LABOR; PREMATURITY; PRENATAL PERIOD; PRIORITY JOURNAL; SMOKING; STREPTOCOCCUS AGALACTIAE; TOCOLYSIS; UTERINE CERVIX; UTERINE CERVIX DISEASE; ADULT; FEMALE; NEWBORN; PREMATURE BIRTH;

ADULT; ANTI-BACTERIAL AGENTS; FEMALE; HUMANS; INFANT, NEWBORN; NEUROPROTECTIVE AGENTS; PREGNANCY; PREMATURE BIRTH; STEROIDS; TOCOLYTIC AGENTS;

EID: 84868094640     PISSN: 19405510     EISSN: 19405529     Source Type: Journal    
DOI: 10.1002/ddrr.124     Document Type: Article

References (26)

1. ACOG Committee Opinion No. 291. 2003. Use of progesterone to prevent preterm birth. American College of Obstetricians and Gynecologists. Obstet Gynecol 102:1115-1116.
2. ACOG Committee Opinion No.455. 2010. Magnesium sulfate before anticipated preterm birth for neuroprotection. American College of Obstetricians and Gynecologists. Obstet Gynecol 115:669-671.
3. Berkman ND, Thorp JM, Lohr KN, et al. 2003. Tocolytic treatment for the management of preterm labor: a review of the evidence. Am J Obstet Gynecol 188:1648-1659.
4. CDC, Centers for Disease Control and Prevention. 2010. Prevention of perinatal group B streptococcal disease. MMWR 59 (No. RR-10)
5. Cunningham FG, Leveno KJ, Bloom SL, et al. 2010. Preterm birth. In:Cunningham FG, Leveno KJ, Bloom SL, et al., editors. Williams Obstetrics, 23rd ed. New York: McGraw Hill Medical. p804-831.
6. Da Fonseca EB, Bittar RE, Carvalho MH, et al. 2003. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol 188:419-424.
7. Elimian A, Garry D, Fiueroa R, et al. 2007. Antenatal betamethasone compared with dexamethasone (Betacode Trial). Obstet Gynecol 110:26-30.
8. Fonseca EB, Celik E, Parra M, et al. 2007. Progesterone and the risk of preterm birth among women with a short cervix. NEJM 357:462-469.
9. Goldenberg RL, Hauth JC, Andrews W. 2000. Intrauterine infection and preterm delivery. NEJM 342:1500-1507.
10. Kamel R. 2010. The onset of human parturition. Arch Gynecol Obstet 281:975-982.
11. King J, Flenady V, Cole S, et al. 2005. Cyclo-oxygenase (COX) inhibitors for treating preterm labor. Cochrane Database Syst Rev 2:CD001992.
12. Lyell DJ, Pullen K, Campbell L, et al. 2007. Magnesium sulfate compared with nifedipine for acute tocolysis of preterm labor. Obstet Gynecol 110:61-67.
13. Mackenzie R, Walker M, Armson A, et al. 2006. Progesterone for the prevention of preterm birth among women at risk: a systematic review and meta-analysis of randomized controlled trials. Am J Obstet Gynecol 194:1234-1242.
14. Martin JA, Kirmeyer S, Osterman M, et al. 2009. Born a bit too early: recent trends in late preterm births. NCHS Data Brief 24:1-8.
15. Martin JA, Osterman MJK, Sutton PD, 2010.Are preterm births on the decline in the United States? Recent data from the National Vital Statistics System. NCHS data brief, no 39. Hyattsville, MD: National Center for Health Statistics.
16. Matthews TJ, MacDorman MF, 2010.Infant mortality statistics from the 2006 period linked birth/infant death data set. National vital statistics reports, vol 58, no 17. Hyattsville, MD: National Center for Health Statistics.
17. Meis PJ, Klebanoff M, Thom E, et al. 2003. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 348:2379-2385.
18. Milligan D, 2010. Outcomes of children born very preterm in Europe. Arch Dis Child Fetal Neonatal Ed 95:F234-F240.
19. Owen, J. 2001. Mid-trimester endovaginal sonography in women at high risk for spontaneous preterm birth. JAMA 286:1340-1348.
20. Peaceman AM, Andrews WW, Thorp JM, et al. 1997. Fetal fibronectin as a predictor of preterm birth in patients with symtpoms: a multicenter trial. Am J Obstet Gynecol 177:13-18.
21. Roberts D, Dalziel SR, 2006. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 3:CD004454; DOI: 10.1002/14651858.CD004454.pub2.
22. Rouse DJ, Hirtz DG, Thorn E, et al. 2008. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. NEJM 359:9:895-905.
23. Simhan H, Cartis S. 2007. Prevention of preterm delivery. NEJM 357:477-487.
24. Smith GC, Pell JP, Dobble R, 2003. Interpregnancy interval and risk of preterm birth and neonatal death: retrospective cohort study. BMJ 327:851
25. Spong CY. 2007. Prediction and prevention of recurrent spontaneous preterm birth. Obstet Gynecol. 110 (2 Pt 1):405-15; Review.
26. Talge NM, Holzman C, Wang J, et al. 2010. Preterm birth and its association with cognitive and socioemotional outcomes at 6 years of age. Pediatrics 126:1124-1131.